Skip to main content

Table 1 shows the baseline characteristics of each included study

From: Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis

Studies

Age (year)

Male (%)

Ht (%)

Ds (%)

Cs (%)

IT/NIT

IT/NIT

IT/NIT

IT/NIT

IT/NIT

Abizaid [30]

63.0/63.0

49.5/63.6

73.3/67.5

60.0/64.0

48.9/48.6

Akin [2]

66.9/66.6

65.4/75.0

92.4/92.6

80.7/83.5

14.9/19.3

Antoniucci [31]

69.0/68.0

65.0/73.0

40.0/43.0

30.0/30.0

17.0/21.0

Dangas [8]

62.6/63.2

61.3/76.5

87.5/83.2

–

17.9/14.7

Hermillier [32]

62.2/62.2

63.5/63.5

81.1/81.1

71.4/71.4

–

Jain [33]

66.6/64.9

62.2/71.8

82.1/77.5

67.9/67.7

13.9/18.0

Kereiakes [34]

63.3/63.3

63.3/63.3

87.0/87.0

82.5/82.5

18.3/18.3

Kirtane [3]

63.0/63.0

64.7/64.7

82.1/82.1

74.0/74.0

18.4/18.4

Kirtane [16]

64.0/64.0

60.4/60.4

90.6/90.6

87.1/87.1

54.1/54.1

Kuchulakanti [35]

65.1/65.1

60.5/60.5

89.0/89.0

88.5/88.5

16.0/16.0

Kumar [15]

62.0/67.0

62.0/67.0

94.0/93.0

89.0/92.0

11.0/8.0

Mehran [36]

63.0/66.0

52.0/61.0

77.0/77.0

71.0/67.0

11.0/12.0

Mulukutla [37]

63.5/64.0

50.7/61.5

84.8/83.1

79.5/77.3

16.9/19.4

Nakamura [38]

66.2/67.2

66.2/75.4

68.1/72.0

58.0/60.4

12.1/19.5

Schofer [39]

60.0/62.0

71.0/77.0

73.0/75.0

65.0/72.0

13.0/20.0

Stein [40]

58.0/60.0

53.1/66.1

56.8/63.0

–

–

Stone [41]

63.8/63.8

63.2/63.2

83.1/83.1

79.4/79.4

19.6/19.6

Tada [1]

66.7/67.9

67.0/76.0

76.0/78.0

–

16.0/21.0

Witzenbichler [42]

64.5/64.5

73.4/73.4

72.3/72.3

60.3/60.3

56.8/56.8

Kappetein [43]

65.4/65.4

71.0/71.0

70.0/70.0

82.0/82.0

16.0/16.0

  1. IT insulin-treated diabetics, NIT non-insulin treated diabetics, Ht hypertension, Ds dyslipidemia, Cs current smoker